Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4283-4290

  Pandori, Mark W ^a   Fitch, Nicholas J S ^b   Craig, Heather M ^b   Richman, Douglas D ^a,b,c   Spina, Celsa A ^b,c   Guatelli, John C ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; NEF PROTEIN; PROTEINASE;

ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROTEIN MODIFICATION; VIRION; VIROGENESIS; VIRUS GENE; VIRUS INFECTIVITY; VIRUS MUTANT;

EID: 0030014162     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4283-4290.1996     Document Type: Article

References (33)

1. Aiken, C., J. Konner, N. R. Landau, M. Lenburg, and D. Trono. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-854.
2. Aiken, C., and D. Trono. 1995. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:5048-5056.
3. Baur, A. S., E. T. Sawai, P. Dazin, W. J. Fantl, C. Cheng-Mayer, and B. M. Peterlin. 1994. HIV-1 nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1:373-384.
4. Benson, R. E., A. Sanfridson, J. S. Ottinger, C. Doyle, and B. R. Cullen. 1993. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus nef prevents viral super infection. J. Exp. Med. 177:1561-1566.
5. Bryant, M., D. Getman, M. Smidt, J. Marr, M. Clare, R. Dillard, D. Lansky, G. DeCrescenzo, R. Heintz, K. Houseman, K. Reed, J. Stolzenbach, J. Talley, M. Vazquez, and R. Mueller. 1995. SC-52151, a novel inhibitor of the human immunodeficiency virus protease. Antimicrob. Agents Chemother. 39:2229-2234.
6. Chesebro, B., and K. Wehrly. 1988. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J. Virol. 62:3779-3788.
7. Chowers, M. Y., M. W. Pandori, C. A. Spina, D. D. Richman, and J. C. Guatelli. 1995. The growth advantage conferred by HIV-1 nef is determined at the level of viral DNA formation and is independent of CD4 downregulation. Virology 212:451-457.
8. Chowers, M. Y., C. A. Spina, T. J. Kwoh, N. J. S. Fitch, D. D. Richman, and J. C. Guatelli. 1994. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J. Virol. 68:2906-2914.
9. Cullen, B. R. 1994. The role of Nef in the replication cycle of the human and simian immunodeficiency viruses. Virology 205:1-6.
10. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, V. A. Lawson, S. Crowe, A. Maerz, S. Sonza, J. Learmont, J. S. Sullivan, A. Cunningham, D. Dwyer, D. Dowton, and J. Mills. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991.
11. de Ronde, A., B. Klaver, W. Keulen, L. Smit, and J. Goudsmit. 1992. Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes. Virology 187:391-395.
12. Du, Z., S. M. Lang, V. G. Sasseville, A. A. Lackner, P. O. Ilvnskii, M. D. Daniel, J. U. Jung, and R. C. Desrosiers. 1995. Identification of a nef ailele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82:655-674.
13. Freund, J., R. Kellner, T. Houthaeve, and H. R. Kalbitzer. 1994. Stability and proteolytic domains of Nef protein from human immunodeficiency virus (HIV) type 1. Eur. J. Biochem. 221:811-819.
14. Freund, J., R. Kellner, J. Konvalinka, V. Wolber, H.-G. Kräusslich, and H. R. Kalbitzer. 1994. A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur. J. Biochem. 223:589-593.
15. Gaedigk-Nitschko, K., A. Schön, G. Wachinger, V. Erfle, and B. Kohleisen. 1995. Cleavage of recombinant and cell derived human immunodeficiency virus 1 (HIV-1) Nef protein by HIV-1 protease. FEBS Lett. 357:275-278.
16. Garcia, J. V., and A. D. Miller. 1991. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature (London) 350:508-511.
17. Goldsmith, M. A., M. T. Warmerdam, R. E. Atchison, M. D. Miller, and W. C. Greene. 1995. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type I Nef. J. Virol. 69:4112-4121.
18. Guy, B., M.-P. Kieny, Y. Reviere, C. La Peuch, K. Dott, M. Girand, L. Montagnier, and J.-P. Lecocq. 1987. HIV F/3′ orf encodes a phosphorylase GTP-binding protein resembling an oncogene product. Nature (London) 330:266-269.
19. Kaminchik, J., N. Bashan, A. Itach, N. Sarver, M. Gorecki, and A. Panet. 1991. Genetic characterization of human immunodeficiency virus type 1 nef gene products translated in vitro and expressed in mammalian cells. J. Virol. 65:583-588.
20. Kestler III, H. W., D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65:651-662.
21. Kim, S., K. Ikeuchi, R. Byrn, J. Groopman, and D. Baltimore. 1989. Lack of negative influence on viral growth by the net gene of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9544-1588.
22. Little, S. J., N. L. Riggs, M. Y. Chowers, N. J. S. Fitch, D. D. Richman, C. A. Spina, and J. C. Guatelli. 1994. Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1. Virology 205:578-582.
23. McKeating, J. A., A. McKnight, and J. P. Moore. 1991. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization. J. Virol. 65:852-860.
24. Miller, M. D., M. T. Warmerdam, I. Gaston, W. C. Greene, and M. B. Feinberg. 1994. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 179:101-113.
25. Miller, M. D., M. T. Warmerdam, K. A. Page, M. B. Feinberg, and W. C. Greene. 1995. Expression of the human immunodeficiency virus type 1 (HIV-1) nef gene during HIV-1 production increases progeny particle infectivity independently of gp160 or viral entry. J. Virol. 69:579-584.
26. Pauza, C. D., J. E. Galindo, and D. D. Richman. 1990. Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent HIV-1 infection of CEM cells. J. Exp. Med. 172:1035-1042.
27. Rhee, S. S., and J. W. Marsh. 1994. HIV-1 Nef activity in murine T cells. J. Immunol. 152:5128-5134.
28. + viruses but not for down-regulation of CD4. EMBO J. 14:484-491.
29. Sawai, E. T., A. S. Baur, M. Peterlin, J. A. Levy, and C. Cheng-Mayer. 1995. A conserved domain and membrane targeting of nef from HIV and SIV are required for association with a cellular serine kinase activity. J. Biol. Chem. 270:15307-15314.
30. Schwartz, O., V. Maréchal, O. Danos, and J.-M. Heard. 1995. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69:4053-4059.
31. Shugars, D. C., M. S. Smith, D. H. Glueck, P. V. Nantermet, F. Seillier-Moiseiwitsch, and R. Swanstrom. 1993. Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J. Virol. 67:4639-4650.
32. Skowronski, J., D. Parks, and R. Mariani. 1993. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12:703-713.
33. Spina, C. A., T. J. Kwoh, M. Y. Chowers, J. C. Guatelli, and D. D. Richman. 1994. The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. J. Exp. Med. 179:115-123.